Comparative Analysis of γ-Cyclodextrin, Perilla Oil, and Their Inclusion Complexes on Liver Injury and Dyslipidemia Associated with Elevated Gastrointestinal 12-Hydroxylated Bile Acid Levels

Overview

Journal Molecules

Publisher MDPI

Date 2025 Jan 25

PMID 39860151

Authors

Keisuke Yoshikiyo

Hidehisa Shimizu

Edward G Nagato

Satoshi Ishizuka

Tatsuyuki Yamamoto

Affiliations

Soon will be listed here.

Abstract

Our previous study demonstrated that γ-cyclodextrin (γ-CD)-perilla oil inclusion complexes increase plasma α-linolenic acid and eicosapentaenoic acid levels in healthy rats without adverse effects. The present study examined the effects of perilla oil, γ-CD, and their inclusion complexes on rats fed cholic acid (CA) to mimic the elevated gastrointestinal 12-hydroxylated (12OH) bile acid levels in high-fat diet-fed rats. Rats fed CA (CA group) tended to have higher AST, ALT, plasma total cholesterol (T-CHO), and triglyceride (TG) levels compared to controls fed a standard diet without CA. Rats fed CA and perilla oil (CA+LP group) showed a tendency for lower AST and plasma TG levels than those in the CA group. Rats fed CA and γ-CD (CA+CD group) had significantly higher AST, ALT, plasma T-CHO, and TG levels than the controls, indicating severe liver injury and dyslipidemia. Rats fed CA and the γ-CD-perilla oil inclusion complex (CA+IC group) had significantly lower AST and ALT levels than the CA+CD rats, with a trend towards lower plasma T-CHO and TG levels. Plasma α-linolenic acid and eicosapentaenoic acid levels were significantly higher in the CA+LP and CA+IC groups than in the controls and CA+CD groups. However, the CA+IC group tended to have lower α-linolenic acid levels and significantly lower eicosapentaenoic acid levels than the CA+LP group. This suggests an accelerated conversion of α-linolenic acid to eicosapentaenoic acid in the CA+IC group, which may contribute to the attenuation of liver injury and dyslipidemia. These findings suggest that γ-CD may exacerbate liver injury and dyslipidemia caused by elevated gastrointestinal 12OH bile acid levels, whereas γ-CD-perilla oil inclusion complexes may ameliorate these effects by altering fatty acid metabolism. Furthermore, we recommend evaluating γ-CD safety in both healthy and pathological models and carefully selecting compounds co-ingested with γ-CD.

References

Uekama K . [Pharmaceutical application of cyclodextrins as multi-functional drug carriers]. Yakugaku Zasshi. 2004; 124(12):909-35. DOI: 10.1248/yakushi.124.909. View

Ichi I, Kono N, Arita Y, Haga S, Arisawa K, Yamano M . Identification of genes and pathways involved in the synthesis of Mead acid (20:3n-9), an indicator of essential fatty acid deficiency. Biochim Biophys Acta. 2013; 1841(1):204-13. DOI: 10.1016/j.bbalip.2013.10.013. View

Di Ciaula A, Garruti G, Lunardi Baccetto R, Molina-Molina E, Bonfrate L, Wang D . Bile Acid Physiology. Ann Hepatol. 2017; 16(Suppl. 1: s3-105.):s4-s14. DOI: 10.5604/01.3001.0010.5493. View

Munro I, Newberne P, Young V, Bar A . Safety assessment of gamma-cyclodextrin. Regul Toxicol Pharmacol. 2004; 39 Suppl 1:S3-13. DOI: 10.1016/j.yrtph.2004.05.008. View

Yoshitsugu R, Kikuchi K, Iwaya H, Fujii N, Hori S, Lee D . Alteration of Bile Acid Metabolism by a High-Fat Diet Is Associated with Plasma Transaminase Activities and Glucose Intolerance in Rats. J Nutr Sci Vitaminol (Tokyo). 2019; 65(1):45-51. DOI: 10.3177/jnsv.65.45. View

Pawar A, Jump D . Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J Biol Chem. 2003; 278(38):35931-9. DOI: 10.1074/jbc.M306238200. View

Yoshikiyo K, Yoshioka Y, Narumiya Y, Oe S, Kawahara H, Kurata K . Thermal stability and bioavailability of inclusion complexes of perilla oil with γ-cyclodextrin. Food Chem. 2019; 294:56-59. DOI: 10.1016/j.foodchem.2019.04.093. View

Shimoda T, Shimizu H, Iwasaki W, Liu H, Kamo Y, Tada K . A diet supplemented with cholic acid elevates blood pressure accompanied by albuminuria in rats. Biosci Biotechnol Biochem. 2023; 87(4):434-441. DOI: 10.1093/bbb/zbad004. View

Salemans J, Nagengast F, Tangerman A, van Schaik A, Hopman W, de Haan A . Effect of ageing on postprandial conjugated and unconjugated serum bile acid levels in healthy subjects. Eur J Clin Invest. 1993; 23(3):192-8. DOI: 10.1111/j.1365-2362.1993.tb00761.x. View

10.

Li P, Killinger B, Ensink E, Beddows I, Yilmaz A, Lubben N . Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease. Metabolites. 2021; 11(1). PMC: 7823437. DOI: 10.3390/metabo11010029. View

11.

Arima H, Motoyama K, Higashi T . Potential Use of Cyclodextrins as Drug Carriers and Active Pharmaceutical Ingredients. Chem Pharm Bull (Tokyo). 2017; 65(4):341-348. DOI: 10.1248/cpb.c16-00779. View

12.

Shimomura I, Shimano H, Korn B, Bashmakov Y, Horton J . Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem. 1998; 273(52):35299-306. DOI: 10.1074/jbc.273.52.35299. View

13.

Serhan C . Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014; 510(7503):92-101. PMC: 4263681. DOI: 10.1038/nature13479. View

14.

Chiang J . Bile acid metabolism and signaling. Compr Physiol. 2013; 3(3):1191-212. PMC: 4422175. DOI: 10.1002/cphy.c120023. View

15.

Haeusler R, Pratt-Hyatt M, Welch C, Klaassen C, Accili D . Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab. 2011; 15(1):65-74. PMC: 3253887. DOI: 10.1016/j.cmet.2011.11.010. View

16.

Ticho A, Malhotra P, Dudeja P, Gill R, Alrefai W . Intestinal Absorption of Bile Acids in Health and Disease. Compr Physiol. 2019; 10(1):21-56. PMC: 7171925. DOI: 10.1002/cphy.c190007. View

17.

Larabi A, Masson H, Baumler A . Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023; 15(1):2172671. PMC: 9904317. DOI: 10.1080/19490976.2023.2172671. View

18.

Loftsson T, Vogensen S, Brewster M, Konradsdottir F . Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci. 2007; 96(10):2532-46. DOI: 10.1002/jps.20992. View

19.

Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E . Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009; 23(6):1946-57. PMC: 2698663. DOI: 10.1096/fj.08-125674. View

20.

Pavlidis P, Powell N, Vincent R, Ehrlich D, Bjarnason I, Hayee B . Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?. Aliment Pharmacol Ther. 2015; 42(7):802-17. DOI: 10.1111/apt.13333. View